3. Arterial blood gas values of PO2 and simultaneously determined PCO2 during steady state exercise breathing room air (level of exercise equivalent to or less than 17.5 ml O2 consumption/kg/min or 5 METs) equal to or less than the values specified in the applicable table III-A or III-B or III-C in 3.02 C2.
3.03
Asthma. With:
A. Chronic asthmatic bronchitis. Evaluate under the criteria for chronic obstructive pulmonary disease in 3.02A;
or
B. Attacks (as defined in 3.00C), in spite of prescribed treatment and requiring physician intervention, occurring at least once every 2 months or at least six times a year. Each in-patient hospitalization for longer than 24 hours for control of asthma counts as two attacks, and an evaluation period of at least 12 consecutive months must be used to determine the frequency of attacks.
3.04
Cystic fibrosis. With:
A. An FEV1 equal to or less than the appropriate value specified in table IV corresponding to the individual's height without shoes. (In cases of marked spinal deformity, see. 3.00E.);
or
B. Episodes of bronchitis or pneumonia or hemoptysis (more than bloodstreaked sputum) or respiratory failure (documented according to 3.00C, requiring physician intervention, occurring at least once every 2 months or at least six times a year. Each inpatient hospitalization for longer than 24 hours for treatment counts as two episodes, and an evaluation period of at least 12 consecutive months must be used to determine the frequency of episodes;
or
C. Persistent pulmonary infection accompanied by superimposed, recurrent, symptomatic episodes of increased bacterial infection occurring at least once every 6 months and requiring intravenous or nebulization antimicrobial therapy.
Table IV
(Applicable only for evaluation under
3.04A - cystic fibrosis)
|
Height without Shoes (centimeters) |
Height without Shoes (inches) |
FEV1 Equal to or less than (L,BTPS) |
|
154 or less |
60 or less |
1.45 |
|
155-159 |
61-62 |
1.55 |
|
160-164 |
63-64 |
1.65 |
|
165-169 |
65-66 |
1.75 |
|
170-174 |
67-68 |
1.85 |
|
175-179 |
69-70 |
1.95 |
|
180 or more |
71 or more |
2.05 |
3.05
[Reserved.]
3.06
Pneumoconiosis
(demonstrated by appropriate imaging techniques). Evaluate under the appropriate criteria in 3.02.
3.07
Bronchiectasis (demonstrated by appropriate imaging techniques). With:
A. Impairment of pulmonary function due to extensive disease. Evaluate under the appropriate criteria in 3.02;
or
B. Episodes of bronchitis or pneumonia or hemoptysis (more than bloodstreaked sputum) or respiratory failure (documented according to 3.00C), requiring physician intervention, occurring at least once every 2 months or at least six times a year. Each inpatient hospitalization for longer than 24 hours for treatment counts as two episodes, and an evaluation of at least 12 consecutive months must be used to determine the frequency of episodes.
3.08
Mycobacterial, mycotic, and other chronic persistent infections of the lung (see 3.00B). Evaluate under the appropriate criteria in 3.02.
3.09
Cor pulmonale secondary to chronic pulmonary vascular hypertension. Clinical evidence of cor pulmonale (documented according to 3.00G) with:
A. Mean pulmonary artery pressure greater than 40 mm Hg;
or
B. Arterial hypoxemia. Evaluate under the criteria in 3.02C2;
or
C. Evaluate under the applicable criteria in 4.02.
3.10
Sleep-related breathing disorders. Evaluate under 3.09 (chronic cor pulmonale), or 12.02 (organic mental disorders).
3.11
Lung transplant. Consider under a disability for 12 months following the date of surgery; thereafter, evaluate the residual impairment.
Back to List of Social Security Impairments / Damages
Back to Top